Skip to content
Clinical Trials
Our Network
Our Story
Clinical Trials
Our Network
Our Story
OnCore Login
Clinical Trials
Current Trials
Publications
Our Network
Clinical Trial Working Groups
Sponsor-Investigators
Fostering an Environment of Mentorship
Member Sites
Partners in Research
About
Our Story
Our Team
Annual Reports
Services
Biorepository & Correlative Services
Rapid Accrual
Efficient Timelines for Activation
Regulatory Compliance
Accurate & Relevant Data
News & Events
HCRN Calendar
Oncology Meetings
Make a Difference
Donate Now
Fundraising Events
Advocacy Organizations
Honor Your Hero
Careers
Contact
OnCore Login
network member
Rhode Island Hospital
Providence, Rhode Island
About Network Member
Website:
https://www.lifespan.org/centers-services/research-and-clinical-trials
https://www.lifespan.org/centers-services/research-and-clinical-trials
Currently Enrolling
HCRN-AML20-472
TAGALONG Trial: Phase II Study of TAGraxofusp and Azacitidine With or Without Venetoclax in Newly Diagnosed Secondary AML after Previous Exposure to HypOmethylatiNG Agents
Cancer areas:
Leukemia
AdventHealth Orlando
Rhode Island Hospital
University of North Carolina Lineberger Comprehensive Cancer Center
Learn More
See clinicaltrials.gov
Current Trials
Our Network
Our Story
X
